Depressive Disorder
Conditions
Brief summary
This is a research aiming to find the effectiveness of an innovative therapy, EL-SHIN THERAPY, in ameliorating depressive symptoms.
Detailed description
This study evaluates the effectiveness of EL-SHIN® Therapy, a novel adjunctive intervention in alleviating depressive symptoms. There are three components in this therapy: 1. Lavender Therapy 2. GRATEFULNESS® Therapy 3. Fasting with exercise and light therapy The study includes two phases: a quantitative clinical trial and a qualitative focus group. Assessments will use DASS-21, MHQoL, and SQS scales with the intervention delivered in English over 3-4 weeks.
Interventions
OTHEREL-SHIN THERAPY
Participants will be randomly assigned to Group A and Group B. Group A : Attend a talk on Malaysia Tourism + current coping strategies. Group B : EL-SHIN® Therapy + current coping strategies. Duration of therapies: 2 weeks Assessments using (i) DASS-21 (ii) MHQoL (iii) SLEEP QUALITY SCALE (SQS) at baseline, after 1st week & 2nd weeks for both groups. Assessment will be done on end of 3rd week to see effect when EL-SHIN Therapy Stopped. Group B participants: Attend a workshop on administration of EL-SHIN® Therapy. Will reinitiate EL-SHIN Therapy on the 4th week and assess on the 8th day to see the effect.
Sponsors
Monash University Malaysia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
Participants will be randomly assigned to either continue standard treatment with a control activity (Group A) or receive EL-SHIN® Therapy alongside their usual care (Group B).
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age: Above 18 yrs old * DASS-21 scores: Moderately Depressed (Score: 14-20), Moderately Anxious (Score: 10-14) & Moderately Stressed (Score: 19-25) * Non-Muslim (Due to legal restriction in Malaysia for this religion) * English literate * Believers in Creationism
Exclusion criteria
* Muslim (legal restrictions in Malaysia for this religion). * Non-English literate (research will be conducted in English only). * Individuals with any other medical conditions or on current medication To reduce potential complications or confounding factors).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| DASS-21 Scale | 3 to 4 weeks | Measuring severity of Depression, Anxiety and Stress Level. Higher score indicating more severity in experiencing these symptoms |
| Mental Health Quality of Life (MHQoL) | 3 to 4 weeks | Measuring quality of life of individuals. Higher score indicating better quality of life. |
| Sleep Quality Scale (SQS) | 3 to 4 weeks | Measuring Sleep Quality of Individuals with higher score denoting more acute sleep problem |
Countries
Malaysia
Contacts
Primary ContactAI SHIN LIM, PHD
Backup ContactAI SHIN LIM
Outcome results
None listed